QAA

Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens

Product code
QAA
Device name
Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens
Device class
Class 2
21 CFR
21 CFR 866.3376
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QAA
Classification and pathway per current FDA publications. Data from openFDA (CC0).